1. |
Dalgetty DM, Medine CN, Iredale JP, et al. Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol 2009; 297: G241-8.
|
|
2.Hara H, Gridelli B, Lin YJ, et al. Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunologic barriers. Liver Transpl 2008; 14:425-34.
|
|
3.Puppi J, Strom SC, Hughes RD, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012; 21:1-10.
|
|
4.Sokal EM. From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives. Cell Prolif 2011; 44:39-43.
|
|
5.Simons BD, Clevers H. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 2011; 145: 851-62.
|
|
6.Ezzat TM, Dhar DK, Newsome PN, et al. Use of hepatocyte and stemcells for treatment of post-resectional liver failure: are we there yet. Liver international 2011; 31:773-84.
|
|
7.Herencia C, Rodríguez-Ariza C, Canalejo A, et al. Differential bone marrow hematopoietic stem cells mobilization in hepatectomized patients. J Gastrointest Surg 2011; 15:1459-67.
|
|
8.Wesson RN, Cameron AM. Stem cells in acute liver failure. Adv Surg 2011; 45:117-30.
|
|
9.Chinese Society of Hepatology and Chinese Society of Infectious Diseases. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Clin Infect Dis 2011; 4:1-13.
|
|
10.Gaia S, Smedile A, Omedè P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006; 45:13-9.
|
|
11.Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-5.
|
|
12.Zhang Z, Liu J, Liu Y et al. Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells. J Cell Physiol 2013; 228:298-305.
|
|
13.Romagnani P, Lasagni L, Romagnani S. Peripheral blood as a source of stem cells for regenerative medicine. Expert Opin Biol Ther 2006; 6:193-202.
|
|
14.Jang YY, Collector MI, Baylin SB, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004; 6:532-9.
|
|
15.Pai M, Zacharoulis D, Milicevic MN, et al. Autologous infusion of expanded mobilized adult bone marrow- derived CD34+ cells into patients with alcoholic liver cisshosis. Am J Gastroenterol. 2008; 103:1952-8.
|
|
16.Wan Z, You S, Rong Y, et al. CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure. Dig Dis Sci 2013; 58:448-57.
|
|
17.Lorenzini S, Gitto S, Grandini E, et al. Stem cells for end stage liver disease: How far have we got? World J Gastroenterol 2008; 14: 4593-9.
|
|
18.Salama H, Zekri ARN, Bahnassy AA, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16: 5297-305.
|
|
19.Piscaglia AC, Campanale M, Gasbarrini A, et al. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int 2010; 2010:259-461.
|
|
20.Alison MR, Islam S, Lim S. Stem cells in liver regene- ration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009; 217:282-98.
|
|
21.Salama H, Zekri AR, Zern M, et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant 2010; 19:1475-86.
|
|
22.Kharaziha P, Hellstrom PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21:1199-205.
|
|
23.Forbes SJ, Newsome Q PN. New horizons for stem cell therapy in liver disease. J Hepatol 2012; 56:496-9.
|
|
24.Nakamura T, Torimura T, Sakamoto M, et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007; 133: 91-107.
|
|
25.Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24:2292-8.
|
|
26.Thomas JA, Pope C, Wojtacha D, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells 250 improving fibrosis, regeneration and function. Hepatology 2011; 53:2003-15.
|